Sponsored Webinars

Recent Advances in Immunotherapy: Directing Cells to Address Disease
Recent Advances in Immunotherapy: Directing Cells to Address Disease

The Scientist is bringing together a panel of experts to review the past, present, and future of immunotherapy, and share the details of their research into new treatments. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Microglial Activation: Understanding Neuroinflammation\'s Origins
Microglial Activation: Understanding Neuroinflammation's Origins

The Scientist is bringing together a panel of experts to review the latest understanding of microglial-induced neuroinflammation and to share their research on mechanisms and medicine. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Trends in Fibrosis Research and Drug Discovery: Nonalcoholic Steatohepatitis (NASH)
Trends in Fibrosis Research and Drug Discovery: Nonalcoholic Steatohepatitis (NASH)

The Scientist is bringing together a panel of experts to discuss the industry-wide trends in cell signaling analysis and molecular pharmacology that are informing the search for NASH therapies, to explore the challenges of identifying therapeutic targets for multifactorial, lifestyle-induced diseases, and to share the latest details of their NASH-directed R&D efforts.

Single-Cell Phenotypic Analysis: Breaking the Law of Averages
Single-Cell Phenotypic Analysis: Breaking the Law of Averages

The Scientist is bringing together a panel of experts to share their experience with single-cell phenotypic analysis and to reflect on the clarity it provides. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

microRNAs: Small but Mighty Tools
microRNAs: Small but Mighty Tools

For a discussion of the current state of disease-specific miRNA profiles and miRNA-based therapeutics, The Scientist is bringing together a panel of experts to share their work with miRNA interventions.